導師簡介

姓名：楊曉峰性別：男政治面貌：中共黨員學歷：研究生學位：博士職稱：教授

博、碩導師：博、碩導師本崗位工作年數：40年

研究方向：光學分子影像外科學(泌尿外科學)

榮譽稱號：中國“UA-吉尼斯(Genius)”醫(yī)療創(chuàng)新大賽冠軍

中國泌尿男科醫(yī)工創(chuàng)新大賽“全國十五強”

山西省新型產業(yè)領軍人才

三晉英才支持計劃高端領軍人才

山西省科技創(chuàng)新人物

學術任職：中華泌尿外科專業(yè)委員會腫瘤組委員

中國醫(yī)師協(xié)會泌尿外科專業(yè)分會膀胱腫瘤協(xié)作組委員

中國醫(yī)學技術協(xié)會生物成像分會常委

中國生物醫(yī)學工程學會生物醫(yī)學光子學分會常委

中國醫(yī)療保健國際交流促進會腔鏡內鏡外科學分會委員

山西省健康協(xié)會泌尿外科專業(yè)委員會主任委員

近五年承擔科研課題情況：

1.中央引導地方科技發(fā)展資金項目項目名稱：智能分子影像內窺鏡的研制和成果轉化,項目編號:YDZJSX2021C010.

山西省科技廳（新立項建設）項目名稱：山西省靶向外科高性能成像工程技術研究中心項目編號: 201805D121007.

代表性論著及近五年的代表性論文（限10項以內）：

1.Multimodal near-infrared molecular imaging of ex vivo endometrial carcinoma via CD47-based targeted tracer, Bioeng Transl Med., 2025, e10754.

2.熒光腹腔鏡根治性膀胱切除術中不同途徑注射吲哚菁綠識別盆腔淋巴結的應用效果,中華泌尿外科雜志, 2024, 45(8): 592-597.

3.Near-infrared fluorescence-assisted superficial inguinal lymph-node excision for lowrisk penile cancer, WORLD J UROL, 2024, 42(1): 206.

4.Fluorescence imaging‐guided pelvic lymph node localization and resection of bladder cancer after intracutaneous injection of indocyanine green into the lower limbs and perineum[J]. UroPrecision. 2024, 2(3): 109?117.

5.Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer, Cellular Oncology, 2023, 46: 1415-1427.

6.主編.光學分子影像外科學[M].北京：中國科學技術出版社, 2021.4ISBN 9787504685063.

7.CD47-targeted optical mo lecular imaging and near-infrared photoimmunotherapy in the detection and treatment of bladder ca ncer, Mol Ther Oncolytics, 2022, 24: 319-330.

8.Ex Vivo Near-Infrared Molecular Imaging of Human Upper Urinary Tract Urothelial Carcinoma With a C D47-Based Targeted Tracer, Front Oncol, 2022, (12): 2022, 12: 825476.

9.Overnight continuous sal ine bladder irrigation after en bloc resection of bladder tumor does not improve oncological outc omes in patients who have received intravesical chemotherapy, Front Oncol, 2021, 11: 638065.

10.Endoscopic molecular imaging plus photoimmunother apy: A new strategy for monitoring and treatment of bladder cancer, Molecular Therapy, 2020, 18: 409-416.